Matches in Nanopublications for { ?s ?p "DDI between Telaprevir and Lomitapide - Telaprevir increases levels by affecting CYP3A4 metabolism. Concomitant therapy is contraindicated. [drugbank_resource:DB05521_DB08827]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.